Jeffrey White
Psychiatric/Mental Health · Delhi, LANPI 1033559174
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 450 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 13.3% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,373, 2.2 times the $1,090 reported in 2021. Among psychiatric/mental health clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 450 payments — averaging $17.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Alkermes, Inc.$1K
- Indivior Inc.$749
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$595
- Axsome Therapeutics, Inc.$561
- Otsuka America Pharmaceutical, Inc.$552
- plus $3K from 13 others
What the payments were for
- Food & beverage$7,57799%
- Education$1101%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $1,025 |
| Alkermes, Inc. | 71 | $1,006 |
| Indivior Inc. | 41 | $749 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 36 | $595 |
| Axsome Therapeutics, Inc. | 33 | $561 |
| Otsuka America Pharmaceutical, Inc. | 36 | $552 |
| Vanda Pharmaceuticals Inc. | 24 | $549 |
| Lundbeck LLC | 32 | $522 |
| Johnson & Johnson | 24 | $464 |
| Corium, LLC | 19 | $374 |
| Sunovion Pharmaceuticals Inc. | 16 | $254 |
| E.r. Squibb & Sons, L.L.C. | 15 | $214 |
| Braeburn Inc. | 9 | $192 |
| Supernus Pharmaceuticals, Inc. | 6 | $176 |
| Teva Pharmaceuticals USA, Inc. | 4 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $147 |
| Avanir Pharmaceuticals, Inc. | 4 | $81 |
| Neurocrine Biosciences, Inc. | 3 | $51 |
| Pfizer | 1 | $21 |
How this compares
$7,687 in reported general payments places this provider in the 90th percentile of 615 psychiatric/mental health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 42 | $66,725 |
| VraylarCariprazine Hcl | 43 | $63,634 |
| Invega SustennaPaliperidone Palmitate | 18 | $54,104 |
| Abilify MaintenaAripiprazole | 11 | $32,030 |
| AuvelityDextromethorphan Hbr/Bupropion | 19 | $19,110 |
| TrintellixVortioxetine Hydrobromide | 33 | $15,782 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 51 | $12,579 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 124 | $2,482 |
| Thiothixene | 13 | $1,752 |
| Divalproex Sodium ErDivalproex Sodium | 26 | $1,639 |
| Aripiprazole | 94 | $1,401 |
| Olanzapine | 41 | $1,323 |
| Quetiapine Fumarate | 106 | $1,002 |
| Oxcarbazepine | 42 | $991 |
| Fluoxetine Hcl | 95 | $971 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena | $552 | $98,75653 claims |
| AbbVieVraylar | $1,025 | $63,63443 claims |
| Johnson & JohnsonInvega Sustenna | $464 | $54,10418 claims |
| Axsome Therapeutics, Inc.Auvelity | $561 | $19,11019 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $147 | $15,78233 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 615 psychiatric/mental health providers in Louisiana.
Other psychiatric/mental health in Delhi
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
- Amber LittlefieldBroussard$225K
- Timothy PellegrinHouma$210K
- Melissa GuilbeauLafayette$122K
- Kimberly ForcinelShreveport$92K
- Sattaria DilksLake Charles$57K
- Joe TaylorHammond$38K
- Lecy AlbaradoScott$34K
- Michelle DyerLake Charles$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.